Flubrotizolam presents itself as a synthetic benzodiazepine compound. Developed for clinical purposes, flubrotizolam possesses intense anxiolytic effects. Its chemical properties illustrate a high affinity for the GABA receptor, leading to significant CNS modulation. Although its potential therapeutic applications, flubrotizolam's unregulated use h